This volume examines findings about trusted sources of vaccine information from the latest KFF Tracking Poll on Health Information and Trust. It also explores how the misrepresentation of studies and policy developments contribute to health narratives around vaccines, HIV and PrEP. Lastly, it summarizes new research on the use of generative AI to counteract vaccine…
GEO Group, one of the nation’s largest private prison contractors, filed a federal lawsuit last month against California officials to strike down a state law allowing local public health officials to inspect immigration detention facilities. The Florida-based company argued in a filing that California’s law, signed by Gov. Gavin Newsom in August, is unconstitutional because…
Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug for preventing influenza infection. A Phase 3 study is already underway, timed to coincide with the start of the flu season in the Northern Hemisphere. The post Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug…
EKALAKA, Mont. — There was no doctor on-site when a patient arrived in early June at the emergency room in the small hospital at the intersection of two dirt roads in this town of 400 residents. There never is. Dahl Memorial’s three-bed emergency department — a two-hour drive from the closest hospital with more advanced…
A coalition of 131 healthcare organizations is backing the Clinical Trial Modernization Act, which aims to expand patient access to clinical trials through financial support and other measures. The post More Than 100 Organizations Back Bill to Expand Patient Access to Clinical Trials appeared first on MedCity News.
Phase 2 data for Cargo Therapeutics’ CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post…
Christina Kashiwada was traveling for work during the summer of 2018 when she noticed a small, itchy lump in her left breast. She thought little of it at first. She did routine self-checks and kept up with medical appointments. But a relative urged her to get a mammogram. She took the advice and learned she…
Behavioral health doesn’t need tech that replaces people. It needs technology that respects them, amplifying what clinicians do best and helping more people get the care they deserve. The post The Behavioral Health AI Boom Is Real. So Are the Risks appeared first on MedCity News.
OAKLAND, Calif. — The patient was in his 60s, an African American man with emphysema. The oximeter placed on his fingertip registered well above the 88% blood oxygen saturation level that signals an urgent risk of organ failure and death. Yet his doctor, Noha Aboelata, believed the patient was sicker than the device showed. So…
The full FDA clinical hold formally halts all tests of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a rare inherited metabolic disorder that leads to excessive eating. Earlier this year, Aardvark voluntarily paused all tests of its small molecule after a cardiovascular problem emerged in a healthy volunteer. The post Under FDA Clinical Hold, Aardvark Therapeutics…